|
1）Horio M, Imai E, Yasuda Y, et al. Comparison of a simple and a standard method for inulin renal clearance. Clin Exp Nephrol. 2010; 14: 427-30
|
|
|
|
2）Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53: 982-92
|
|
|
|
|
|
3）Deen WM, Robertson CR, Brenner BM. A model of glomerular ultrafiltration in the rat. Am J Physiol. 1972; 223: 1178-83
|
|
|
|
|
|
4）Huang SHS, Sharma AP, Yasin A, et al. Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin J Am Soc Nephrol. 2011; 6: 274-80
|
|
|
|
|
|
5）National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Diseas: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S46-S75
|
|
|
|
|
|
6）Odutayo A, Hladunewich M. Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol. 2012; 7: 2073-80
|
|
|
|
|
|
7）Helal I, Fick-Brosnahan GM, Reed-Gitomer B, et al. Glomerular hyperfiltration: definitions, mechnisms and clinical implications. Nat Rev Nephrol. 2012; 8: 293-300
|
|
|
|
|
|
8）Novak J, Danielson LA, Kechner LJ, et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest. 2001; 107: 1469-75
|
|
|
|
|
|
9）Conrad KP, Debrah DO, Novak J, et al. Relaxin modifies systemic arterial resistance and compliance in conscious rats. Endocrinology. 2004; 145: 3289-96
|
|
|
|
|
|
10）Jeyabalan A, Novak J, Danielson LA, et al. Essential role of vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res. 2003; 93:1249-57
|
|
|
|
|
|
11）Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998; 54: 2056-63
|
|
|
|
|
|
12）Vervoort G, Veldman B, Berden JH, et al. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest. 2005; 35: 330-6
|
|
|
|
|
|
13）Jerums G, Premaratne E, Panagiotopoulos S, et al. The clinical significance of hyperfiltration in diabetes. Diabetologia. 2010; 53: 2093-104
|
|
|
|
|
|
14）Chen HM, Liu ZH, Zeng CH, et al. Podocyte lesions in patients with obesity-related glomerulo-pathy. Am J Kidney Dis. 2006; 48: 772-9
|
|
|
|
|
|
15）Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominat polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol. 2006; 1: 148-57
|
|
|
|
|
|
16）Meijer E, Rook M, Tent H, et al. Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2010; 5: 1091-8
|
|
|
|
|
|
17）Torres VE, King BF, Chapman AB, et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2007; 2: 112-20
|
|
|
|
|
|
18）Helal I, Reed B, McFann K, et al. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011; 6: 2439-43
|
|
|
|
|
|
19）Wuerzner G, Pruijm M, Maillard M, et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis. 2010; 56: 303-12
|
|
|
|
|
|
20）Levey AS, Kramer H. Obesity, glomerular hyperfiltration, and surface area correction. Am J Kidney Dis. 2010; 56: 255-8
|
|
|
|
|
|
21）Goumenos DS, Kawar B, El Nahas M, et al. Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant. 2009; 24: 3732-8
|
|
|
|
|
|
22）Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008; 23: 3946-52
|
|
|
|
|
|
23）Serpa Neto A, Bianco Rossi FM, et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol. 2009; 22: 637-46
|
|
|
|
|
|
24）Horio M, Imai E, Yasuda Y, et al. Performance of GFR equations in Japanese subjects. Clin Exp Nephrol. 2013; 17: 352-8
|
|
|
|
|
|
25）Horio M, Imai E, Yasuda Y, et al. GFR estima-tion using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013; 61: 197-203
|
|
|
|
|
|
26）Horio M, Imai E, Yasuda Y, et al. Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol. 2011; 15: 868-76
|
|
|
|
|